My mother was diagnosed with stage 3b CRC over 5 years ago, when she was 66-67 years old. She had immediate surgery to remove a large mass from her abdominal region and then underwent chemotherapy (5FU + Oxaliplatin). Within between 1-2 years after that, a routine scan picked up another mass, so she had to have another operation, again, in the in the abdominal region, to remove it. However, this time, after surgery, it was found that the cancer had metastasized to the peritoneal region. It was determined that another surgery to remove it would not be advisable since the surgeon was concerned about (a) whether she would be able to handle another surgery due to how tough the other two surgeries were on her and how difficult it may be having surgery in the peritoneal region, and (b) because it had metastasized, the oncologist said that another surgery to remove the spread in the peritoneal region may not resolve the issue since it had already metastasized. At this point, she was said to have stage 4 CRC.
Fortunately, the oncologist said she was part of a small percentage of candidates for immunotherapy, as she was MSI-H. The options were Keytruda or Opdivo, or Opdivo + Yervoy. The oncologist asked if my mother prioritized quality of life or increased risk and potential lower quality of life if it meant more effective treatment, and my mother did find quality of life to be important to her, so she settled on Keytruda. The oncologist said Opdivo + Yervoy would be more toxic and have more side effects, and Opdivo was about the same effectiveness as Keytruda. The oncologist also said that with immunotherapy, there is no telling how a patient may respond and it could lead to serious side effects. I read up on Opdivo + Yervoy and it seems the combination tackles 2 different pathways and may be more effective, but also could come with more side effects. After settling on Keytruda, the initial treatments seemed to work, as her CEA dropped from like 60 to 30 or so. Gradually, her CEA started creeping up by 1-4 after nearly every blood test every 3 weeks. In the past few months, the CEA had gone down by 4, then up about 4, then down about 4. She has had zero side effects from Keytruda. This past weekend, my mother then had another scan and it showed some progression, after months of scans showing general stability and no real progression. She's not had any pain, loss of appetite, or loss or weight. She could feel a mass on the lower left side of her belly and noticed it getting smaller by feel of the hand as she received Keytruda infusions. After her recent scan this weekend, I asked if she could feel anything different and she said it felt like there were additional masses in the same area, but the original mass felt like it hasn't grown.
Tomorrow we have a video appointment with her oncologist to discuss other treatments, and her next 2 Keytruda appointments scheduled for tomorrow and 3 weeks later have been cancelled. I've asked her oncologist about HIPEC and she said it was a very drastic procedure and if my mother valued quality of life then she wouldn't recommend HIPEC. I've also asked about possibly trying Opdivo + Yervoy since it tackles 2 pathways, to see if that could make a difference over Keytruda. The oncologist said she wasn't aware of any research showing it would make a difference.
So, at this point, I'm wondering what treatment options we should look at as my mother's best option at this point:
1. Opdivo + Yervoy, to see if it yields better results than Keytruda.
2. HIPEC
3. Going back to chemotherapy but something other than 5FU + Oxaliplatin (since she experienced a recurrence after the 1st surgery and chemo that used those drugs after she was first diagnosed)
4. Ask about targeted cell therapies or any new developments that she could try.
Not looking for medical advice, just some feedback from as many as possible about what may be the best options to look into or pursue.
Thanks in advance.